Literature DB >> 9042032

Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic.

A H Ahmed1, K G Nicholson, J S Nguyen-van Tam, J C Pearson.   

Abstract

The effectiveness of influenza vaccine in reducing hospital admissions for pneumonia, influenza, bronchitis, or emphysema was assessed by a case-control study of people aged 16 years and older who were admitted to 10 Leicestershire hospitals between 1 December 1989 and 31 January 1990. Hospital and general practitioners' records for 156 admissions (the cases) and 289 controls matched for age and sex were reviewed. Information was collected on demography, the usual place of residence (institutional or non-institutional), the existence of chronic illness, and vaccination during the 5 years before admission. The odds ratio for hospital admission among vaccinees was 0.67 (95% CI 0.39-1.12) giving an estimate of vaccine effectiveness in this setting of 33% (95% CI 0-61). However, multivariate logistic regression, adjusting for the effects of institutional care and chronic illness, revealed that influenza vaccination reduced hospital admissions by 63% (95% CI 17-84%). There was a strong trend towards improved vaccine effectiveness when used in institutional settings. Influenza vaccine is effective in reducing hospital admissions for influenza, pneumonia, bronchitis and emphysema, and effectiveness is comparable to that observed for influenza and pneumonia admissions in North America.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042032      PMCID: PMC2808769          DOI: 10.1017/s0950268896007121

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

Authors:  L J Tata; J West; T Harrison; P Farrington; C Smith; R Hubbard
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

2.  The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years.

Authors:  K L Nichol; M Goodman
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 3.  Influenza vaccination in the elderly: impact on hospitalisation and mortality.

Authors:  Kristin L Nichol
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Surveillance of respiratory virus infections in adult hospital admissions using rapid methods.

Authors:  M Kaye; S Skidmore; H Osman; M Weinbren; R Warren
Journal:  Epidemiol Infect       Date:  2006-01-03       Impact factor: 2.451

5.  Influenza vaccination in asthma: a primary care experience.

Authors:  A Innes; E Beresford; J Bedford
Journal:  Br J Gen Pract       Date:  2000-01       Impact factor: 5.386

6.  Decreased immune responses to influenza vaccination in patients with heart failure.

Authors:  Orly Vardeny; Nancy K Sweitzer; Michelle A Detry; John M Moran; Maryl R Johnson; Mary S Hayney
Journal:  J Card Fail       Date:  2008-12-18       Impact factor: 5.712

7.  Decreased T-cell responses to influenza vaccination in patients with heart failure.

Authors:  Orly Vardeny; John J M Moran; Nancy K Sweitzer; Maryl R Johnson; Mary S Hayney
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

8.  Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.

Authors:  Roberto Gasparini; Daniela Amicizia; Piero Luigi Lai; Stefania Rossi; Donatella Panatto
Journal:  Hum Vaccin Immunother       Date:  2012-11-10       Impact factor: 3.452

Review 9.  Prevention and control of influenza in persons with chronic obstructive pulmonary disease.

Authors:  Pedro Plans-Rubió
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Vaccines for preventing influenza in the elderly.

Authors:  Vittorio Demicheli; Tom Jefferson; Carlo Di Pietrantonj; Eliana Ferroni; Sarah Thorning; Roger E Thomas; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.